BBC startup announces CD4 Shield to mitigate COVID-19
Bangalore-based Stabicon, which is incubated at Bangalore Bioinnoavtion Centre (BBC), has launched CD4 Shield. The start-up has been working on prevention program for the novel coronavirus (nCOV-19) using the company’s proprietary Zuicel technology.
"We never exported vaccines at the cost of Indians," says Serum Institute
In a statement, Serum Institute of India said that the company has not exported vaccines at the cost of Indians. It also states that SII remains committed to do everything they can in support of the vaccination drive in the country.